7 results
6-K
EX-99.1
MOR
Morphosys AG
13 Mar 24
Non-Financial Group Report 2023
4:12pm
Organization and Anti- Corruption 8 Bioethics in Clinical Development 9 Selling Practices and Labeling This chapter deals with MorphoSys’ compliance … organization and anti-corruption strategy, bioethics in clinical development, and selling practices and labeling. Compliance Organization and Anti
6-K
EX-99.3
MOR
Morphosys AG
7 Feb 24
MorphoSys Enters into Business Combination Agreement to be
6:57am
. German Stock Corporation Act.
“Anti-Corruption Laws”
shall mean the Foreign Corrupt Practices Act of 1977, as amended, the Anti-Kickback Act of 1986 … Restricted Stock Unit Program
Acceptance Period
Ad Hoc Announcement
ADS
Affiliate
Agreement
Anti-Corruption Laws
Antitrust Laws
Assumption of Defense
6-K
EX-99.1
MOR
Morphosys AG
16 Mar 22
Current report (foreign)
5:13pm
of Products Access to Medicine Innovation in Research and Development (R&D) Data Protection Compliance Organization and Anti-Corruption Selling … and Compliance Compliance Organization and Anti-Corruption ––––––––––––––––––– 08 Bioethics in Preclinical Research ––––––––– 10 Bioethics
SC TO-T
EX-99
MOR
Morphosys AG
16 Jun 21
Third party tender offer statement
4:52pm
requirements;
regulatory matters;
compliance with anti-corruption and anti-bribery laws;
permits and licenses;
tax matters;
employees and employee
6-K
EX-99.1
MOR
Morphosys AG
23 Mar 21
Current report (foreign)
3:53pm
Compliance area, the focus is on anti-bribery and anti-corruption. MorphoSys AG – Planegg — Annual Financial Statements as of December 31, 2020
Management
6-K
EX-99.1
qbld28v
27 Mar 20
Current report (foreign)
3:29pm
6-K
EX-99.1
q8artpy9i yc7740nrf
20 Mar 20
Current report (foreign)
2:15pm
- Prev
- 1
- Next